1 – 10 of 81
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- The role of interleukin-17A in the pathogenesis of kidney diseases (
- The intriguing role of soluble urokinase receptor in inflammatory diseases (
- Alterations of CXCL12 in serum of patients with vitiligo (
- S100B is a potential disease activity marker in nonsegmental vitiligo (
- Biomarkers of disease activity in vitiligo : a systematic review (
- A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma : evaluation of clinical and immunologic response (
- Mechanisms and consequences of carbamoylation. (
- Secukinumab : IL-17A inhibition to treat psoriatic arthritis (
- Meeting report: Vitiligo Global Issues Consensus Conference Workshop 'Outcome measurement instruments' and Vitiligo International Symposium, Rome, Nov 30-Dec 3rd (
- Segmental vitiligo (